Impact of Depression and Psychosocial Treatment on Heart Rate Variability in Patients with Type 2 Diabetes Mellitus: An Exploratory Analysis Based on the HEIDIS Trial

Verena Zimmermann-Schlegel; Beate Wild; Peter Nawroth; Stefan Kopf; Wolfgang Herzog; Mechthild Hartmann

doi:10.1055/s-0043-125445

Experimental and Clinical Endocrinology & Diabetes, Inhaltsverzeichnis

Exp Clin Endocrinol Diabetes 2019; 127(06): 367-376
DOI: 10.1055/s-0043-125445

Article

Impact of Depression and Psychosocial Treatment on Heart Rate Variability in Patients with Type 2 Diabetes Mellitus: An Exploratory Analysis Based on the HEIDIS Trial

Verena Zimmermann-Schlegel

¹Department of General Internal Medicine & Psychosomatics, Heidelberg University Hospital, Heidelberg, Germany

,

Beate Wild

¹Department of General Internal Medicine & Psychosomatics, Heidelberg University Hospital, Heidelberg, Germany

,

Peter Nawroth

²Department of Endocrinology and Metabolism; Heidelberg University Hospital, German Center of Diabetes Research (DZD), Heidelberg, Germany

,

Stefan Kopf

²Department of Endocrinology and Metabolism; Heidelberg University Hospital, German Center of Diabetes Research (DZD), Heidelberg, Germany

,

Wolfgang Herzog

¹Department of General Internal Medicine & Psychosomatics, Heidelberg University Hospital, Heidelberg, Germany

,

Mechthild Hartmann

¹Department of General Internal Medicine & Psychosomatics, Heidelberg University Hospital, Heidelberg, Germany

› Institutsangaben

Abstract

Objectives To explore the impact of depression on heart rate (HR) and heart rate variability (HRV) as a marker of autonomic nervous system (ANS) impairment in depressed and non-depressed patients with advanced type 2 diabetes mellitus (T2DM) and to explore possible effects of an acceptance- and mindfulness-based group intervention (MBSR) on HR and HRV.

Methods Alongside a prospective clinical trial, we collected demographic, psychosocial and clinical data from 113 chronic T2DM patients in a standardized setting. At baseline and after one year, depressive mood was assessed with the Patient Health Questionnaire (PHQ-9), and autonomic function was determined by measuring HR and HRV markers. A subsample was randomly assigned to take part in eight MBSR sessions.

Results Of the 113 T2DM patients (77.9% men; mean age=58.8±7.0 years; diabetes duration 11.5±7.0 years), 33 showed clinically relevant depressive symptoms at baseline. In cross-sectional analysis, we found no association between depression and HR/HRV (all comparisons p>0.05). In prospective regression analysis depression did not predict follow-up scores of HRV. The patients who participated in the MBSR intervention showed a tendency toward improved parasympathetic control (RMSSD, CV, E-I-Ratio) with small-to-moderate effect sizes (d≤0.38).

Conclusions Depression was not directly associated with cardiac autonomic control in this sample, but MBSR training may have positively influenced HR and HRV. In advanced diabetes, somatic and behavioral parameters seem to be more predictive than depression for the course of autonomic functioning, but the pathways remain unclear.

Key words

autonomic nervous system - depression - heart rate variability - microalbuminuria - type 2 diabetes mellitus

Volltext

Referenzen

References
1 Bruce DG, Davis WA, Hunter ML. et al. Lifetime depression history and depression risk in type 2 diabetes: A case-control study. J Diabetes Complications 2016; 30: 38-42
2 Nicolau J, Simo R, Sanchis P. et al. Prevalence and clinical correlators of undiagnosed significant depressive symptoms among individuals with type 2 diabetes in a mediterranean population. Exp Clin Endocrinol Diabetes 2016; 124: 630-636
3 Jacob L, Kostev K. Prevalence of depression in type 2 diabetes patients in German primary care practices. J Diabetes Complications 2016; 30: 432-437
4 Larsen KK, Christensen B, Nielsen TJ. et al. Post-myocardial infarction anxiety or depressive symptoms and risk of new cardiovascular events or death: A population-based longitudinal study. Psychosomatic Medicine 2014; 76: 739-746
5 Hofmann M, Kohler B, Leichsenring F. et al. Depression as a risk factor for mortality in individuals with diabetes: A meta-analysis of prospective studies. PloS One 2013; 8: e79809
6 Watkins LL, Koch GG, Sherwood A. et al. Association of anxiety and depression with all-cause mortality in individuals with coronary heart disease. J Am Heart Assoc 2013; 2: e000068
7 Freedland KE, Carney RM. Depression as a risk factor for adverse outcomes in coronary heart disease. BMC Med 2013; 11: 131
8 Laborde S, Mosley E, Thayer JF. Heart rate variability and cardiac vagal tone in psychophysiological research - recommendations for experiment planning, data analysis, and data reporting. Front Psychol 2017; 8: 213
9 Kop WJ, Stein PK, Tracy RP. et al. Autonomic nervous system dysfunction and inflammation contribute to the increased cardiovascular mortality risk associated with depression. Psychosom Med 2010; 72: 626-635 DOI: PSY.0b013e3181eadd2b [pii];10.1097/PSY.0b013e3181eadd2b [doi]
10 Aydin Sunbul E, Sunbul M, Gulec H. The impact of major depression on heart rate variability and endothelial dysfunction in patients with stable coronary artery disease. Gen Hosp Psychiatry 2017; 44: 4-9
11 Licht CM, Naarding P, Penninx BW. et al. The association between depressive disorder and cardiac autonomic control in adults 60 years and older. Psychosom Med 2015; 77: 279-291
12 Carney RM, Howells WB, Blumenthal JA. et al. Heart rate turbulence, depression, and survival after acute myocardial infarction. Psychosom Med 2007; 69: 4-9 DOI: 01.psy.0000249733.33811.00 [pii];10.1097/01.psy.0000249733.33811.00 [doi]
13 Rawshani A, Rawshani A, Franzen S. et al. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med 2017; 376: 1407-1418
14 Schroeder EB, Chambless LE, Liao D. et al. Diabetes, glucose, insulin, and heart rate variability: The Atherosclerosis Risk in Communities (ARIC) study. Diabetes Care 2005; 28: 668-674
15 Jaiswal M, Fingerlin TE, Urbina EM. et al. Impact of glycemic control on heart rate variability in youth with type 1 diabetes: The SEARCH CVD study. Diabetes technology & therapeutics 2013; 15: 977-983
16 Ziegler D, Zentai C, Perz S. et al. Selective contribution of diabetes and other cardiovascular risk factors to cardiac autonomic dysfunction in the general population. Exp Clin Endocrinol Diabetes 2006; 114: 153-159
17 National Kidney F. KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update. American journal of kidney diseases: the official journal of the National Kidney Foundation 2012; 60: 850-886
18 Moran A, Palmas W, Field L. et al Cardiovascular autonomic neuropathy is associated with microalbuminuria in older patients with type 2 diabetes. Diabetes Care 2004; 27: 972-977
19 Nolan RP, Jong P, Barry-Bianchi SM. et al. Effects of drug, biobehavioral and exercise therapies on heart rate variability in coronary artery disease: a systematic review. European journal of cardiovascular prevention and rehabilitation: Official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 2008; 15: 386-396
20 Strachowski D, Khaylis A, Conrad A. et al. The effects of cognitive behavior therapy on depression in older patients with cardiovascular risk. Depression and Anxiety 2008; 25: E1-10
21 Ismail K, Winkley K, Rabe-Hesketh S. Systematic review and meta-analysis of randomised controlled trials of psychological interventions to improve glycaemic control in patients with type 2 diabetes. Lancet 2004; 363: 1589-1597
22 Baumeister H, Hutter N, Bengel J. Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depression. Cochrane Database Syst Rev 2012; 12: CD008381
23 Bundesärztekammer (BÄK) KBK, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF). Nationale Versorgungsleitlinie Therapie des Typ-2-Diabetes - Langfassung. In. 1. Edition Version 4 2013 ed 2014
24 Kopf S, Oikonomou D, Hartmann M. et al. Effects of stress reduction on cardiovascular risk factors in type 2 diabetes patients with early kidney disease - results of a randomized controlled trial (HEIDIS). Experimental and clinical endocrinology & diabetes: Official journal, German Society of Endocrinology [and] German Diabetes Association 2014; 122: 341-349
25 Lowe B, Grafe K, Zipfel S. et al. Diagnosing ICD-10 depressive episodes: Superior criterion validity of the Patient Health Questionnaire. Psychother Psychosom 2004; 73: 386-390
26 Manea L, Gilbody S, McMillan D. Optimal cut-off score for diagnosing depression with the Patient Health Questionnaire (PHQ-9): A meta-analysis. CMAJ 2012; 184: E191-E196
27 Kroenke K. Enhancing the clinical utility of depression screening. CMAJ 2012; 184: 281-282
28 Kabat-Zinn J, Massion AO, Kristeller J. et al. Effectiveness of a meditation-based stress reduction program in the treatment of anxiety disorders. The American Journal of Psychiatry 1992; 149: 936-943
29 Faude-Lang V, Hartmann M, Schmidt EM. et al. [Acceptance- and mindfulness-based group intervention in advanced type 2 diabetes patients: therapeutic concept and practical experiences]. Psychotherapie, Psychosomatik, medizinische Psychologie 2010; 60: 185-189
30 Hartmann M, Kopf S, Kircher C. et al. Sustained effects of a mindfulness-based stress-reduction intervention in type 2 diabetic patients: Design and first results of a randomized controlled trial (the Heidelberger Diabetes and Stress-study). Diabetes Care 2012; 35: 945-947
31 Cohen J. A power primer. Psychological bulletin 1992; 112: 155-159
32 Taylor CB. Depression, heart rate related variables and cardiovascular disease. International journal of psychophysiology: Official journal of the International Organization of Psychophysiology 2010; 78: 80-88
33 Kop WJ, Stein PK, Tracy RP. et al. Autonomic nervous system dysfunction and inflammation contribute to the increased cardiovascular mortality risk associated with depression. Psychosom Med 2010; 72: 626-635 DOI: PSY.0b013e3181eadd2b [pii];10.1097/PSY.0b013e3181eadd2b [doi]
34 Chen HC, Yang CC, Kuo TB. et al. Gender differences in the relationship between depression and cardiac autonomic function among community elderly. International Journal of Geriatric Psychiatry 2010; 25: 314-322
35 Schonauer M, Thomas A, Morbach S. et al. Cardiac autonomic diabetic neuropathy. Diab Vasc Dis Res 2008; 5: 336-344 DOI: 3174 [pii];10.3132/dvdr.2008.047 [doi]
36 Oliveira NL, Ribeiro F, Teixeira M. et al. Effect of 8-week exercise-based cardiac rehabilitation on cardiac autonomic function: A randomized controlled trial in myocardial infarction patients. Am Heart J 2014; 167: 753-761 e753
37 Sridhar B, Haleagrahara N, Bhat R. et al. Increase in the heart rate variability with deep breathing in diabetic patients after 12-month exercise training. Tohoku J Exp Med 2010; 220: 107-113
38 Nahshoni E, Aravot D, Aizenberg D. et al. Heart rate variability in patients with major depression. Psychosomatics 2004; 45: 129-134
39 Carney RM, Freedland KE, Steinmeyer BC. et al. Nighttime heart rate predicts response to depression treatment in patients with coronary heart disease. J Affect Disord 2016; 200: 165-171
40 Francis JL, Weinstein AA, Krantz DS. et al. Association between symptoms of depression and anxiety with heart rate variability in patients with implantable cardioverter defibrillators. Psychosomatic medicine 2009; 71: 821-827
41 Lowe B, Spitzer RL, Grafe K. et al. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians’ diagnoses. J Affect Disord 2004; 78: 131-140
42 Munoz ML, van Roon A, Riese H. et al. Validity of (Ultra-)short recordings for heart rate variability measurements. PLoS One 2015; 10: e0138921
43 Gonzalez JS, Peyrot M, McCarl LA. et al. Depression and diabetes treatment nonadherence: A meta-analysis. Diabetes Care 2008; 31: 2398-2403
44 Barr ELM, Cunningham J, Tatipata S. et al. Associations of mortality and cardiovascular disease risks with diabetes and albuminuria in urban Indigenous Australians: The DRUID follow-up study. Diabet Med 2017; 34: 946-957
45 Wiltink J, Michal M, Wild PS. et al. Associations between depression and diabetes in the community: Do symptom dimensions matter? Results from the Gutenberg Health Study. PloS one 2014; 9: e105499
46 de Jonge P, Mangano D, Whooley MA. Differential association of cognitive and somatic depressive symptoms with heart rate variability in patients with stable coronary heart disease: Findings from the Heart and Soul Study. Psychosom Med 2007; 69: 735-739
47 Gehi A, Mangano D, Pipkin S. et al Depression and heart rate variability in patients with stable coronary heart disease: Findings from the Heart and Soul Study. Arch Gen Psychiatry 2005; 62: 661-666 DOI: 62/6/661 [pii];10.1001/archpsyc.62.6.661 [doi]
48 Bar KJ, Greiner W, Jochum T. et al. The influence of major depression and its treatment on heart rate variability and pupillary light reflex parameters. J Affect Disord 2004; 82: 245-252 DOI: S016503270400031X [pii];10.1016/j.jad.2003.12.016 [doi]
49 Bhattacharyya MR, Whitehead DL, Rakhit R. et al. Depressed mood, positive affect, and heart rate variability in patients with suspected coronary artery disease. Psychosom Med 2008; 70: 1020-1027 DOI: PSY.0b013e318189afcc [pii];10.1097/PSY.0b013e318189afcc [doi]